197 related articles for article (PubMed ID: 17380789)
1. HMGB1 as a potential therapeutic target.
Wang H; Li W; Goldstein R; Tracey KJ; Sama AE
Novartis Found Symp; 2007; 280():73-85; discussion 85-91, 160-4. PubMed ID: 17380789
[TBL] [Abstract][Full Text] [Related]
2. The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis.
Wang H; Li W; Li J; Rendon-Mitchell B; Ochani M; Ashok M; Yang L; Yang H; Tracey KJ; Wang P; Sama AE
J Nutr; 2006 Feb; 136(2):360-5. PubMed ID: 16424112
[TBL] [Abstract][Full Text] [Related]
3. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1.
Li W; Li J; Ashok M; Wu R; Chen D; Yang L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
J Immunol; 2007 Mar; 178(6):3856-64. PubMed ID: 17339485
[TBL] [Abstract][Full Text] [Related]
4. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1.
Li W; Ashok M; Li J; Yang H; Sama AE; Wang H
PLoS One; 2007 Nov; 2(11):e1153. PubMed ID: 17987129
[TBL] [Abstract][Full Text] [Related]
5. HMGB1 as a cytokine and therapeutic target.
Yang H; Wang H; Czura CJ; Tracey KJ
J Endotoxin Res; 2002; 8(6):469-72. PubMed ID: 12697092
[TBL] [Abstract][Full Text] [Related]
6. Extracellular role of HMGB1 in inflammation and sepsis.
Wang H; Yang H; Tracey KJ
J Intern Med; 2004 Mar; 255(3):320-31. PubMed ID: 14871456
[TBL] [Abstract][Full Text] [Related]
7. Structural basis for the proinflammatory cytokine activity of high mobility group box 1.
Li J; Kokkola R; Tabibzadeh S; Yang R; Ochani M; Qiang X; Harris HE; Czura CJ; Wang H; Ulloa L; Wang H; Warren HS; Moldawer LL; Fink MP; Andersson U; Tracey KJ; Yang H
Mol Med; 2003; 9(1-2):37-45. PubMed ID: 12765338
[TBL] [Abstract][Full Text] [Related]
8. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Bae JS
Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
[TBL] [Abstract][Full Text] [Related]
9. Caging a Beast in the Inflammation Arena: Use of Chinese Medicinal Herbs to Inhibit a Late Mediator of Lethal Sepsis, HMGB1.
Zhu S; Li W; Li J; Sama AE; Wang H
Int J Clin Exp Med; 2008; 1(1):64-75. PubMed ID: 19079688
[TBL] [Abstract][Full Text] [Related]
10. Ghrelin protects against experimental sepsis by inhibiting high-mobility group box 1 release and by killing bacteria.
Chorny A; Anderson P; Gonzalez-Rey E; Delgado M
J Immunol; 2008 Jun; 180(12):8369-77. PubMed ID: 18523304
[TBL] [Abstract][Full Text] [Related]
11. PACAP inhibit the release and cytokine activity of HMGB1 and improve the survival during lethal endotoxemia.
Tang Y; Lv B; Wang H; Xiao X; Zuo X
Int Immunopharmacol; 2008 Dec; 8(12):1646-51. PubMed ID: 18713653
[TBL] [Abstract][Full Text] [Related]
12. More tea for septic patients?--Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines.
Chen X; Li W; Wang H
Med Hypotheses; 2006; 66(3):660-3. PubMed ID: 16266789
[TBL] [Abstract][Full Text] [Related]
13. Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis.
Yang M; Cao L; Xie M; Yu Y; Kang R; Yang L; Zhao M; Tang D
Biochem Pharmacol; 2013 Aug; 86(3):410-8. PubMed ID: 23707973
[TBL] [Abstract][Full Text] [Related]
14. Suppression of HMGB1 release by stearoyl lysophosphatidylcholine:an additional mechanism for its therapeutic effects in experimental sepsis.
Chen G; Li J; Qiang X; Czura CJ; Ochani M; Ochani K; Ulloa L; Yang H; Tracey KJ; Wang P; Sama AE; Wang H
J Lipid Res; 2005 Apr; 46(4):623-7. PubMed ID: 15687351
[TBL] [Abstract][Full Text] [Related]
15. HMGB1 as a DNA-binding cytokine.
Andersson U; Erlandsson-Harris H; Yang H; Tracey KJ
J Leukoc Biol; 2002 Dec; 72(6):1084-91. PubMed ID: 12488489
[TBL] [Abstract][Full Text] [Related]
16. The cytokine activity of HMGB1.
Yang H; Wang H; Czura CJ; Tracey KJ
J Leukoc Biol; 2005 Jul; 78(1):1-8. PubMed ID: 15734795
[TBL] [Abstract][Full Text] [Related]
17. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation.
Ulloa L; Ochani M; Yang H; Tanovic M; Halperin D; Yang R; Czura CJ; Fink MP; Tracey KJ
Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12351-6. PubMed ID: 12209006
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of HMGB1 during experimental sepsis modulates the inflammatory cytokine profile to one associated with improved clinical outcomes.
Stevens NE; Chapman MJ; Fraser CK; Kuchel TR; Hayball JD; Diener KR
Sci Rep; 2017 Jul; 7(1):5850. PubMed ID: 28724977
[TBL] [Abstract][Full Text] [Related]
19. High mobility group box-1 as a therapeutic target downstream of tumor necrosis factor.
Czura CJ; Yang H; Tracey KJ
J Infect Dis; 2003 Jun; 187 Suppl 2():S391-6. PubMed ID: 12792856
[TBL] [Abstract][Full Text] [Related]
20. Bench to bedside: HMGB1-a novel proinflammatory cytokine and potential therapeutic target for septic patients in the emergency department.
Sama AE; D'Amore J; Ward MF; Chen G; Wang H
Acad Emerg Med; 2004 Aug; 11(8):867-73. PubMed ID: 15289194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
